Interaction of Acetylcholinesterase with Neurexin-1β Regulates Glutamatergic Synaptic stability in Hippocampal neurons

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  Xiang, Yun Yan ^a,b   Dong, Haiheng ^c   Yang, Burton B ^d   Macdonald, John F ^a,b   Lu, Wei Yang ^a,b,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Glycosylation; Neurodegeneration; Protein interaction; Synaptic apoptosis

Indexed keywords

ACETYLCHOLINESTERASE; GLUTAMIC ACID; NEUREXIN; NEUREXIN 1BETA; NEUROLIGIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; ENZYME INACTIVATION; GLUTAMATERGIC SYNAPSE; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL; NEURITE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SYNAPSE; SYNAPTOGENESIS;

ACETYLCHOLINESTERASE; ANIMALS; CELL ADHESION MOLECULES, NEURONAL; CELL MEMBRANE; GLUTAMATES; GLYCOSYLATION; HEK293 CELLS; HIPPOCAMPUS; HUMANS; IMMUNOPRECIPITATION; LIGANDS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURONS; PROTEIN BINDING; RATS; RATS, WISTAR; RNA SPLICING; SYNAPSES;

EID: 84898047235     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-7-15     Document Type: Article

References (78)

1. Acetylcholinesterase-new roles for an old actor. Soreq H, Seidman S, Nat Rev Neurosci 2001 2 294 302 10.1038/35067589 11283752
2. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Perrier AL, Massoulie J, Krejci E, Neuron 2002 33 275 285 10.1016/S0896-6273(01)00584-0 11804574
3. Membrane targeting, shedding and protein interactions of brain acetylcholinesterase. Hicks D, John D, Makova NZ, Henderson Z, Nalivaeva NN, Turner AJ, J Neurochem 2011 116 742 746 10.1111/j.1471-4159.2010.07032.x 21214569
4. Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Johnston MV, McKinney M, Coyle JT, Proc Natl Acad Sci USA 1979 76 5392 5396 10.1073/pnas.76.10.5392 388436
5. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. Aubert I, Poirier J, Gauthier S, Quirion R, J Neurosci 1994 14 2476 2484 8182423
6. Acetylcholinesterase is increased in mouse neuronal and astrocyte cultures after treatment with beta-amyloid peptides. Saez-Valero J, Fodero LR, White AR, Barrow CJ, Small DH, Brain Res 2003 965 283 286 10.1016/S0006-8993(02) 04159-8 12591148
7. Alzheimer's disease: a disorder of cortical cholinergic innervation. Coyle JT, Price DL, DeLong MR, Science 1983 219 1184 1190 10.1126/science. 6338589 6338589
8. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH, J Neurochem 1986 47 263 277 3711902
9. Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Fishman EB, Siek GC, MacCallum RD, Bird ED, Volicer L, Marquis JK, Ann Neurol 1986 19 246 252 10.1002/ana.410190305 3963769
10. Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. Navaratnam DS, Priddle JD, McDonald B, Esiri MM, Robinson JR, Smith AD, Lancet 1991 337 447 450 10.1016/0140-6736(91)93391-L 1671469
11. Acetylcholinesterase in Alzheimer's disease. Talesa VN, Mech Ageing Dev 2001 122 1961 1969 10.1016/S0047-6374(01)00309-8 11589914
12. Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease. Saez-Valero J, Sberna G, McLean CA, Masters CL, Small DH, Lancet 1997 350 929 10.1016/S0140-6736(97)24039-0 9314873
13. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. Alvarez A, Opazo C, Alarcon R, Garrido J, Inestrosa NC, J Mol Biol 1997 272 348 361 10.1006/jmbi.1997.1245 9325095
14. Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes. Munoz FJ, Inestrosa NC, FEBS Lett 1999 450 205 209 10.1016/S0014-5793(99)00468-8 10359075
15. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S, Neurobiol Aging 2003 24 777 787 10.1016/S0197-4580(02)00230-0 12927760
16. Alzheimer's disease is a synaptic failure. Selkoe DJ, Science 2002 298 789 791 10.1126/science.1074069 12399581
17. Neuroligin 1: a splice site-specific ligand for beta-neurexins. Ichtchenko K, Hata Y, Nguyen T, Ullrich B, Missler M, Moomaw C, Sudhof TC, Cell 1995 81 435 443 10.1016/0092-8674(95)90396-8 7736595
18. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Song JY, Ichtchenko K, Sudhof TC, Brose N, Proc Natl Acad Sci USA 1999 96 1100 1105 10.1073/pnas.96.3.1100 9927700
19. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Dean C, Dresbach T, Trends Neurosci 2006 29 21 29 16337696
20. Making connections: cholinesterase-domain proteins in the CNS. Scholl FG, Scheiffele P, Trends Neurosci 2003 26 618 624 10.1016/j.tins.2003.09.004 14585602
21. Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. Dong H, Xiang YY, Farchi N, Ju W, Wu Y, Chen L, Wang Y, Hochner B, Yang B, Soreq H, Lu WY, Trends Neurosci 2004 24 8950 8960
22. Neurons segregate clusters of membrane-bound acetylcholinesterase along their neurites. Rotundo RL, Carbonetto ST, Proc Natl Acad Sci USA 1987 84 2063 2067 10.1073/pnas.84.7.2063 3470777
23. Neurexin mediates the assembly of presynaptic terminals. Dean C, Scholl FG, Choih J, DeMaria S, Berger J, Isacoff E, Scheiffele P, Nat Neurosci 2003 6 708 716 10.1038/nn1074 12796785
24. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I, Nat Med 1996 2 1382 1385 10.1038/nm1296-1382 8946841
25. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Meshorer E, Soreq H, Trends Neurosci 2006 29 216 224 10.1016/j.tins.2006.02.005 16516310
26. Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels. Chitlaru T, Kronman C, Zeevi M, Kam M, Harel A, Ordentlich A, Velan B, Shafferman A, Biochem J 1998 336 Pt 3 647 658 9841877
27. The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580 - Ala mutant. Velan B, Grosfeld H, Kronman C, Leitner M, Gozes Y, Lazar A, Flashner Y, Marcus D, Cohen S, Shafferman A, J Biol Chem 1991 266 23977 23984 1748670
28. Cellular expression of a cloned, hydrophilic, murine acetylcholinesterase. Evidence of palmitoylated membrane-bound forms. Randall WR, J Biol Chem 1994 269 12367 12374 7512968
29. Bovine acetylcholinesterase: cloning, expression and characterization. Mendelson I, Kronman C, Ariel N, Shafferman A, Velan B, Biochem J 1998 334 Pt 1 251 259 9693127
30. Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time. Chitlaru T, Kronman C, Velan B, Shafferman A, Biochem J 2002 363 619 631 10.1042/0264-6021:3630619 11964163
31. N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Velan B, Kronman C, Ordentlich A, Flashner Y, Leitner M, Cohen S, Shafferman A, Biochem J 1993 296 Pt 3 649 656 8280063
32. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration. Andres C, Beeri R, Friedman A, Lev-Lehman E, Henis S, Timberg R, Shani M, Soreq H, Proc Natl Acad Sci U S A 1997 94 8173 8178 10.1073/pnas.94.15.8173 9223334
33. Conserved domain structure of beta-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins. Ushkaryov YA, Hata Y, Ichtchenko K, Moomaw C, Afendis S, Slaughter CA, Sudhof TC, J Biol Chem 1994 269 11987 11992 8163501
34. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. Graf ER, Kang Y, Hauner AM, Craig AM, J Neurosci 2006 26 4256 4265 10.1523/JNEUROSCI.1253-05.2006 16624946
35. Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase. Shafferman A, Ordentlich A, Barak D, Kronman C, Ber R, Bino T, Ariel N, Osman R, Velan B, EMBO J 1994 13 3448 3455 8062821
36. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin. Radic Z, Kirchhoff PD, Quinn DM, McCammon JA, Taylor P, J Biol Chem 1997 272 23265 23277 10.1074/jbc.272.37.23265 9287336
37. Mouse acetylcholinesterase interacts in yeast with the extracellular matrix component laminin-1beta. Paraoanu LE, Layer PG, FEBS Lett 2004 576 161 164 10.1016/j.febslet.2004.08.078 15474030
38. Mouse acetylcholinesterase enhances neurite outgrowth of rat R28 cells through interaction with laminin-1. Sperling LE, Klaczinski J, Schutz C, Rudolph L, Layer PG, PLoS One 2012 7 36683 10.1371/journal.pone.0036683 22570738
39. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Scheiffele P, Fan J, Choih J, Fetter R, Serafini T, Cell 2000 101 657 669 10.1016/S0092-8674(00)80877-6 10892652
40. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Silman I, Sussman JL, Curr Opin Pharmacol 2005 5 293 302 10.1016/j.coph.2005.01.014 15907917
41. Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Layer PG, Weikert T, Alber R, Cell Tissue Res 1993 273 219 226 10.1007/BF00312823 8103422
42. Impaired formation of the inner retina in an AChE knockout mouse results in degeneration of all photoreceptors. Bytyqi AH, Lockridge O, Duysen E, Wang Y, Wolfrum U, Layer PG, Eur J Neurosci 2004 20 2953 2962 10.1111/j.1460-9568.2004. 03753.x 15579149
43. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. Beeri R, Le Novere N, Mervis R, Huberman T, Grauer E, Changeux JP, Soreq H, J Neurochem 1997 69 2441 2451 9375677
44. Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact. Andres C, Seidman S, Beeri R, Timberg R, Soreq H, Neurochem Int 1998 32 449 456 10.1016/S0197-0186(97)00121-6 9676744
45. Chicken retinospheroids as developmental and pharmacological in vitro models: acetylcholinesterase is regulated by its own and by butyrylcholinesterase activity. Layer PG, Weikert T, Willbold E, Cell Tissue Res 1992 268 409 418 10.1007/BF00319147 1628298
46. Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta. Comoletti D, Flynn R, Jennings LL, Chubykin A, Matsumura T, Hasegawa H, Sudhof TC, Taylor P, J Biol Chem 2003 278 50497 50505 10.1074/jbc.M306803200 14522992
47. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J, Neuron 1996 16 881 891 10.1016/S0896-6273(00)80108-7 8608006
48. Changes in read through acetylcholinesterase expression modulate amyloid-beta pathology. Berson A, Knobloch M, Hanan M, Diamant S, Sharoni M, Schuppli D, Geyer BC, Ravid R, Mor TS, Nitsch RM, Soreq H, Brain 2008 131 109 119 18056160
49. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I, Science 1991 253 872 879 10.1126/science. 1678899 1678899
50. Human acetylcholinesterase binds to mouse laminin-1 and human collagen IV by an electrostatic mechanism at the peripheral anionic site. Johnson G, Moore SW, Neurosci Lett 2003 337 37 40 10.1016/S0304-3940(02)01298-3 12524166
51. Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. Barak D, Kronman C, Ordentlich A, Ariel N, Bromberg A, Marcus D, Lazar A, Velan B, Shafferman A, J Biol Chem 1994 269 6296 6305 8119978
52. Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex reveal specific protein-protein and protein-Ca2+ interactions. Arac D, Boucard AA, Ozkan E, Strop P, Newell E, Sudhof TC, Brunger AT, Neuron 2007 56 992 1003 10.1016/j.neuron.2007.12.002 18093522
53. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Krall WJ, Sramek JJ, Cutler NR, Ann Pharmacother 1999 33 441 450 10.1345/aph.18211 10332536
54. Cholinesterases preceding major tracts in vertebrate neurogenesis. Layer PG, Bioessays 1990 12 415 420 10.1002/bies.950120904 2256905
55. Postnatal development of cortical acetylcholinesterase-rich neurons in the rat brain: permanent and transient patterns. Geula C, Mesulam MM, Kuo CC, Tokuno H, Exp Neurol 1995 134 157 178 10.1006/exnr.1995.1046 7556536
56. The postnatal expression of acetylcholinesterase in somatostatin-positive cells of mouse hippocampus. Forloni G, Blake K, Hohmann CH, Coyle JT, Brain Res Dev Brain Res 1989 48 73 85 10.1016/0165-3806(89)90094-1 2752576
57. Chronic variable stress alters inflammatory and cholinergic parameters in hippocampus of rats. Tagliari B, Tagliari AP, Schmitz F, da Cunha AA, Dalmaz C, Wyse AT, Neurochem Res 2011 36 487 493 10.1007/s11064-010-0367-0 21184279
58. Clomipramine treatment in neonatal rats alters the brain acetylcholinesterase activity in adulthood. Mavanji V, Datta S, Neurosci Lett 2002 330 119 121 10.1016/S0304-3940(02)00725-5 12213647
59. The role of the read through variant of acetylcholinesterase in anxiogenic effects of predator stress in mice. Adamec R, Head D, Soreq H, Blundell J, Behav Brain Res 2008 189 180 190 10.1016/j.bbr.2007.12.023 18243359
60. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H, Curr Biol 1995 5 1063 1071 10.1016/S0960-9822(95) 00211-9 8542283
61. Control of excitatory and inhibitory synapse formation by neuroligins. Chih B, Engelman H, Scheiffele P, Science 2005 307 1324 1328 10.1126/science.1107470 15681343
62. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM, Cell 2004 119 1013 1026 10.1016/j.cell.2004.11.035 15620359
63. Cell-cell signaling during synapse formation in the CNS. Scheiffele P, Ann Rev Neurosci 2003 26 485 508 10.1146/annurev.neuro.26.043002.094940 12626697
64. Neuroligins and neurexins link synaptic function to cognitive disease. Sudhof TC, Nature 2008 455 903 911 10.1038/nature07456 18923512
65. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H, Immunity 2009 31 965 973 10.1016/j.immuni.2009.09. 019 20005135
66. Alteration of the microRNA network during the progression of Alzheimer's disease. Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, Rothman R, Sierksma AS, Thathiah A, Greenberg D, Papadopoulou AS, Achsel T, Ayoubi T, Soreq H, Verhaagen J, Swaab DF, Aerts S, De SB, EMBO Mol Med 2013 5 1613 1634 10.1002/emmm.201201974 24014289
67. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL, Am J Psychiatry 2001 158 1058 1066 10.1176/appi.ajp.158.7.1058 11431227
68. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. Sternfeld M, Ming G, Song H, Sela K, Timberg R, Poo M, Soreq H, J Neurosci 1998 18 1240 1249 9454834
69. Structures, alternative splicing, and neurexin binding of multiple neuroligins. Ichtchenko K, Nguyen T, Sudhof TC, J Biol Chem 1996 271 2676 2682 10.1074/jbc.271.5.2676 8576240
70. Neurexins are functional alpha-latrotoxin receptors. Sugita S, Khvochtev M, Sudhof TC, Neuron 1999 22 489 496 10.1016/S0896-6273(00)80704-7 10197529
71. Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. Yang BL, Cao L, Kiani C, Lee V, Zhang Y, Adams ME, Yang BB, J Biol Chem 2000 275 21255 21261 10.1074/jbc.M001443200 10801813
72. SUMO-1 modification activates the transcriptional response of p53. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT, EMBO J 1999 18 6455 6461 10.1093/emboj/18.22.6455 10562557
73. Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme. Velan B, Kronman C, Grosfeld H, Leitner M, Gozes Y, Flashner Y, Sery T, Cohen S, Ben Aziz R, Seidman S, Cell Mol Neurobiol 1991 11 143 156 10.1007/BF00712806 1849451
74. Increased transforming growth factor-beta1 modulates glutamate receptor expression in the hippocampus. Bae JJ, Xiang YY, Martinez-Canabal A, Frankland PW, Yang BB, Lu WY, Int J Physiol Pathophysiol Pharmacol 2011 3 9 20 21479098
75. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. Brewer GJ, Torricelli JR, Evege EK, Price PJ, J Neurosci Res 1993 35 567 576 10.1002/jnr.490350513 8377226
76. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. Xiang YY, Dong H, Wan Y, Li J, Yee A, Yang BB, Lu WY, J Biol Chem 2006 281 19358 19368 10.1074/jbc.M512980200 16648628
77. Variability of distribution of Ca(2+)/calmodulin-dependent kinase II at mixed synapses on the mauthner cell: colocalization and association with connexin 35. Flores CE, Cachope R, Nannapaneni S, Ene S, Nairn AC, Pereda AE, J Neurosci 2010 30 9488 9499 10.1523/JNEUROSCI.4466-09.2010 20631177
78. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. Darreh-Shori T, Hellstrom-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A, J Neurochem 2004 88 1102 1113 10.1046/j.1471-4159.2003.02230.x 15009666